ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $740K of Zentalis Pharmaceuticals, Inc.
Sold$740,337
$74.03Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Thu, Dec 16 close, $76.57
- −25.5%
- S&P 500, same days
- −3.2%
Measured over 30 trading days, to the Jan 31 close.
Traded Wed, Dec 15. Filed Thu, Dec 16, 12:18 PM ET, during the session. Returns use the Dec 16 close and the Jan 31 close. Not investment advice.